Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Acceptability of a novel vaginal microbicide during a safety trial among low-risk women.

Acceptability of a novel vaginal microbicide during a safety trial among low-risk women. Fam Plann Perspect. 2000 Jul-Aug; 32(4):184-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.